Research & Literature

Dermatologic Diagnosis: Leukocytoclastic Vasculitis.

Einhorn J, Levis JT

The Permanente journal 2015; (19(3)):77-8 doi:10.7812/TPP/15-001.

Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: A retrospective study in 112 patients.

Bouiller K, Audia S, Devilliers H, et al.

Medicine 2016; (95(28)):e4238 doi:10.1097/MD.0000000000004238.

Warfarin-induced leukocytoclastic vasculitis and proteinuria.

Jumean K, Arqoub AA, Hawatmeh A, et al.

Journal of family medicine and primary care 2016; (5(1)):160-2 doi:10.4103/2249-4863.184643.

Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall.

Takatu CM, Heringer APR, Aoki V, et al.

Immunologic research 2017; (65(1)):395-401 doi:10.1007/s12026-016-8850-6.

Clinical study on single-organ cutaneous small vessels vasculitis (SoCSVV).

Pastuszczak M, Celińska-Löwenhoff M, Sułowicz J, et al.

Medicine 2017; (96(12)):e6376 doi:10.1097/MD.0000000000006376.

Levetiracetam-induced leukocytoclastic vasculitis.

Gupta M

Indian journal of pharmacology 2017; (49(1)):124-126 doi:10.4103/0253-7613.201020.

Cefazolin as a cause of leukocytoclastic vasculitis.

Ali N, Karia N, Goldhahn R

Clinical case reports 2017; (5(6)):1051-1053 doi:10.1002/ccr3.992.

Successful Treatment of Cutaneous Small Vessel Vasculitis With Leflunomide.

Stiegler JD, Sami N

JAMA dermatology 2017; (153(9)):940-942 doi:10.1001/jamadermatol.2017.1316.

Outline of guidelines for the management of vasculitis and vascular disorders in Japan, 2016 revised edition.

Ikeda T, Furukawa F, Kawakami T, et al.

The Journal of dermatology 2018; (45(2)):122-127 doi:10.1111/1346-8138.14086.

A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban.

Dean R, Messer AM, Pickett M, Jahan-Tigh R

Dermatology online journal 2017; (23(11)).

Vasculitis of small and large vessels, a casual association?

Pedro F, Abuowda Y, Craveiro N, et al.

Revista da Associacao Medica Brasileira (1992) 2018; (64(7)):590-594 doi:10.1590/1806-9282.64.07.590.

Prognosis and future developments in vasculitis.

Basu N, Karabayas M, Pusey C

Best practice & research. Clinical rheumatology 2018; (32(1)):148-165 doi:10.1016/j.berh.2018.08.011.

Dermatologic Aspects of Systemic Vasculitis.

Younger DS, Carlson A

Neurologic clinics 2019; (37(2)):465-473 doi:10.1016/j.ncl.2019.01.017.

Colloidal Silver Ingestion Associated with Leukocytoclastic Vasculitis in an Adolescent Female.

Mohan N, Gomez C, Khawar N, et al.

The American journal of case reports 2019; (20()):730-734 doi:10.12659/AJCR.915499.

Leukocytoclastic vasculitis: An uncommon adverse effect of a common drug.

Sheoran A, Mahto SK, Verma P, et al.

Journal of family medicine and primary care 2019; (8(6)):2137-2139 doi:10.4103/jfmpc.jfmpc_338_19.

Warfarin induced leukocytoclastic vasculitis: an extraordinary side effect.

Elantably D, Mourad A, Elantably A, Effat M

Journal of thrombosis and thrombolysis 2020; (49(1)):149-152 doi:10.1007/s11239-019-01924-8.

Cutaneous necrotizing small-vessel vasculitis induced by acute hepatitis E.

Viallard JF, Vergier B, Lazaro E, et al.

Clinical case reports 2019; (7(8)):1539-1541 doi:10.1002/ccr3.2167.

The color of skin: purple diseases of the skin, nails, and mucosa.

Steuer AB, Cohen JM

Clinics in dermatology 2019; (37(5)):528-547 doi:10.1016/j.clindermatol.2019.07.016.

Early diagnosis and treatment of Leukocytoclastic Vasculitis: case report.

Bezerra AS, Polimanti AC, de Oliveira RA, et al.

Jornal vascular brasileiro 2020; (19()):e20180072 doi:10.1590/1677-5449.190072.

Improving quality of life in vasculitis patients.

Aitken M, Basu N

Rheumatology (Oxford, England) 2020; (59(Suppl 3)):iii132-iii135 doi:10.1093/rheumatology/kez546.

A detailed analysis of the distribution, morphology, and histopathology of complex purpura in hospitalized patients: A case series of 68 patients.

Gehlhausen JR, Wetter DA, Nelson C, et al.

Journal of the American Academy of Dermatology 2021; (84(4)):1188-1196 doi:10.1016/j.jaad.2020.04.149.

An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient.

Negrini S, Guadagno A, Greco M, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(11)):e675-e676 doi:10.1111/jdv.16760.

Management of cutaneous vasculitis.

Micheletti RG, Pagnoux C

Presse medicale (Paris, France : 1983) 2020; (49(3)):104033 doi:10.1016/j.lpm.2020.104033.

ANCA-associated vasculitis.

Kitching AR, Anders HJ, Basu N, et al.

Nature reviews. Disease primers 2020; (6(1)):71 doi:10.1038/s41572-020-0204-y.

Widespread cutaneous small vessel vasculitis secondary to COVID-19 infection.

Tahir A, Sohail Z, Nasim B, Parmar NV

International journal of dermatology 2020; (59(10)):1278-1279 doi:10.1111/ijd.15106.

Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Mohamoud M, Horgan C, Eworuke E, et al.

Pharmacotherapy 2020; (40(11)):1099-1107 doi:10.1002/phar.2468.

Exuberant bullous vasculitis associated with SARS-CoV-2 infection.

Gouveia PADC, Cipriano IC, de Melo MAZ, et al.

IDCases 2021; (23()):e01047 doi:10.1016/j.idcr.2021.e01047.

Diagnosis and management of leukocytoclastic vasculitis.

Fraticelli P, Benfaremo D, Gabrielli A

Internal and emergency medicine 2021; (16(4)):831-841 doi:10.1007/s11739-021-02688-x.

Very Early-Onset Inflammatory Bowel Disease (VEO-IBD) Presenting with Recurrent Leukocytoclastic Vasculitis Preceded by Streptococcal Pharyngitis.

Fonseca A, Sunny J, Felipez LM

Case reports in pediatrics 2021; (2021()):1996430 doi:10.1155/2021/1996430.

Urticarial vasculitis.

Gu SL, Jorizzo JL

International journal of women's dermatology 2021; (7(3)):290-297 doi:10.1016/j.ijwd.2021.01.021.

Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.

Zhu KJ, Yang PD, Xu Q

Frontiers in immunology 2021; (12()):695768 doi:10.3389/fimmu.2021.695768.

Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination.

Berry CT, Eliliwi M, Gallagher S, et al.

JAAD case reports 2021; (15()):11-14 doi:10.1016/j.jdcr.2021.07.002.

Cutaneous leukocytoclastic vasculitis induced by thiamazole.

Sato A, Takemori C, Fukumoto T, et al.

The Journal of dermatology 2021; (48(12)):e604-e605 doi:10.1111/1346-8138.16205.

Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.

Fiorillo G, Pancetti S, Cortese A, et al.

Journal of autoimmunity 2022; (127()):102783 doi:10.1016/j.jaut.2021.102783.

Vasculitis in the setting of COVID-19: From the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization.

Criado PR, Giordani LP, Yoshimoto TA, et al.

Dermatologic therapy 2022; (35(5)):e15367 doi:10.1111/dth.15367.

[Cutaneous Vasculitides - Clinical Manifestations, Diagnosis, and Aetiology].

Bircher AJ, Pelloni L, Terrani I, et al.

Therapeutische Umschau. Revue therapeutique 2022; (79(5)):238-246 doi:10.1024/0040-5930/a001356.

A Cross-Sectional Study to Correlate Serum Complement C3 and C4 Levels With Clinical and Pathological Severity in Cutaneous Small-Vessel Vasculitis.

Sarkar N, Palit A, Sethy M, et al.

Cureus 2022; (14(5)):e24845 doi:10.7759/cureus.24845.

Cephalexin-Induced Leukocytoclastic Vasculitis.

Tang W, Tan J

Cureus 2022; (14(7)):e26545 doi:10.7759/cureus.26545.

Leukocytoclastic Vasculitis Induced by Cocaine Adulterated with Levamisole.

Barbotti A, Gheorghiu AC, Fusi-Schmidhauser T, Grazioli-Gauthier L

European journal of case reports in internal medicine 2022; (9(7)):003468 doi:10.12890/2022_003468.

Chronic Venous Insufficiency in A Selected Nurse Population: A Cross-Sectional Study.

Xiang Y, Zhou Q, Wu Z, Gou J

Angiology 2024; (75(1)):29-35 doi:10.1177/00033197221130571.

Leukocytoclastic vasculitis in a patient with syphilis and HIV coinfection.

Ariza Ordoñez N, Sepúlveda VG, Marín AP, et al.

Revista do Instituto de Medicina Tropical de Sao Paulo 2022; (64()):e65 doi:10.1590/S1678-9946202264065.

Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management.

Micheletti RG

American journal of clinical dermatology 2023; (24(1)):89-95 doi:10.1007/s40257-022-00736-6.

Systemic disease in leukocytoclastic vasculitis: a focus on direct immunofluorescence findings.

Ertekin SS, Koku Aksu AE, Leblebici C, et al.

Anais brasileiros de dermatologia 2023; (98(1)):59-67 doi:10.1016/j.abd.2021.11.009.

A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations.

Salehi S, Sadeghi S, Kalantari Y, Goodarzi A

The American Journal of dermatopathology 2023; (45(1)):1-27 doi:10.1097/DAD.0000000000002320.

Leukocytoclastic Vasculitis Masquerading as Chronic Idiopathic Thrombocytopenic Purpura.

Tasnim S, Yousuf H, Al-Hilli Y, et al.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS 2022; (39(11)):e0337 doi:10.12788/fp.0337.

Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Complication From a Commonly Used Medication.

Singh I, Gidda H, Nashed B

Cureus 2023; (15(3)):e36532 doi:10.7759/cureus.36532.

A case of erythema elevatum diutinum after COVID-19 vaccination.

Muna B

Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(9)):e1102-e1103 doi:10.1111/jdv.19188.

Gabapentin-Induced Cutaneous Leukocytoclastic Vasculitis: A Case Report.

Órfão A, Madeira D, Maia Duarte D, et al.

Cureus 2023; (15(9)):e44616 doi:10.7759/cureus.44616.

Clinical study on single-organ cutaneous small vessels vasculitis: a retrospective observational study.

Bodakçi E

European review for medical and pharmacological sciences 2024; (28(2)):534-541 doi:10.26355/eurrev_202401_35051.

Leukocytoclastic vasculitis caused by sulfamethoxazole-trimethoprim.

Bhatt P, Montreuil N, Olayiwola A, et al.

Clinical case reports 2024; (12(2)):e8437 doi:10.1002/ccr3.8437.

Segmental cutaneous leukocytoclastic vasculitis associated with herpes zoster: a case report and literature review.

Furuoka K, Fukumoto T, Masuda Y, et al.

Dermatology reports 2023; (15(4)):9709 doi:10.4081/dr.2023.9709.

Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains.

Rhodes RH, Love GL, Da Silva Lameira F, et al.

Diagnostic pathology 2024; (19(1)):33 doi:10.1186/s13000-024-01445-w.

Differences in risk profile associated with varicose veins and chronic venous insufficiency - results from the Bonn Vein Study 1.

Kraus AL, Rabe E, Kowall B, et al.

VASA. Zeitschrift fur Gefasskrankheiten 2024; (53(2)):145-154 doi:10.1024/0301-1526/a001115.

Comparison of clinical and laboratory data of adult patients with cutaneous IgA vasculitis and non-IgA vasculitis.

Gambichler T, Bui D, Domin B, et al.

Clinical and experimental dermatology 2024; (49(8)):859-865 doi:10.1093/ced/llae062.

Secondary syphilis presenting as leukocytoclastic vasculitis in a 61-year-old man.

Mohamed N, Dacy NN, Lopez LM, Bicknell LM

Dermatology online journal 2023; (29(5)) doi:10.5070/D329562402.

Anti-C1q antibodies in IgG4-related disease are common and associated with renal involvement and cutaneous small-vessel vasculitis.

Martín-Nares E, Nuñez-Álvarez CA, Hernández-Molina G

Rheumatology (Oxford, England) 2025; (64(6)):3701-3709 doi:10.1093/rheumatology/keaf020.

High detection rate for perivascular deposits of immunoglobulins in immune complex vasculitis from biopsies of early macular lesions.

Herda L, Michl C, Sunderkötter C

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2025; (23(4)):479-485 doi:10.1111/ddg.15636.

Henoch-Schönlein Purpura Without Proven Immunoglobin A Deposition: A Diagnostic Distinction.

Froberg PW, Ruml A, Fernandez JK

Cureus 2025; (17(4)):e82312 doi:10.7759/cureus.82312.

Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.

Alpsoy E, Caproni M, Wetter DA, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(6)):946-962 doi:10.1111/jdv.70249.

Cutaneous leukocytoclastic vasculitis leading to extensive digital necrosis as the only COVID-19 clinical manifestation.

Pouy R, Bermejo M, Durlach A, Bani-Sadr F

Vascular diseases (Paris, France) 2026; (51(2)):97-99 doi:10.1016/j.vasdi.2025.12.003.